Demeditec Diagnostics

What Demeditec Diagnostics does

Demeditec Diagnostics GmbH is a privately held German specialty diagnostics company headquartered in Kiel, founded in 1987 and operating with 11-50 employees. The company develops and supplies immunoassay test kits for clinical laboratories, research institutions (universities, hospitals, pharmaceutical companies), veterinary practices, and food safety laboratories across more than 19 product categories spanning endocrinology, infectious disease, allergy, autoimmunity, cardiovascular disease, diabetes, thyroid, tumor markers, reproductive health, salivary diagnostics, and veterinary diagnostics.

The core product portfolio is built on three immunoassay technology platforms: ELISA (enzyme-linked immunosorbent assay), RIA (radioimmunoassay), and IRMA (immunoradiometric assay), with additional rapid test formats. Demeditec differentiates through long-tail specialty content that larger competitors do not cover — most notably species-specific veterinary assays (including unique worldwide offerings for rats, mice, dogs, cats, cattle, horses, and camels) and a salivary diagnostics capability developed since 2006 that eliminates sample extraction steps for free steroid measurement. The portfolio also includes differentiated clinical products such as the EndomKIT endometriosis diagnostic (CE-certified, combining BDNF and CA125 biomarkers with a validated algorithm) and is supplemented through distribution partnerships with Diagnostics Biochem Canada Inc. (DBC) and IBL Japan for endocrinology and neurology assays. The company holds ISO 9001 and ISO 13485 certifications, and many products are CE-marked and IVDR-compliant.

Revenue is generated through one-time sale of physical test kits via a B2B quote-based ordering system accessed through the company website. Distribution combines direct website sales with a strategic partnership with DBC for global reach, supplemented by active participation in international trade fairs (MEDICA, ADLM, WHX Labs Dubai, DGK Herztage). Pricing is not publicly disclosed; customers request infopackages and receive customized quotes, with periodic discounts offered for short-expiry products. The company is owned and operated by three listed representatives (Gustav Detlev Horn, Dr. Arndt Stüber, Frederik Horn), with no disclosed institutional investment, parent company, or M&A activity.

Name

Demeditec Diagnostics

Legal name

Demeditec Diagnostics GmbH

Website

https://demeditec.com

Company type

Private

Founded year

1987

Operating status

Operating

Headcount range

1–10 employees

Short description

Demeditec Diagnostics GmbH is a privately held German specialty diagnostics company, founded in 1987 and headquartered in Kiel, that develops and supplies ELISA, RIA, IRMA, and rapid immunoassay test kits to clinical laboratories, research institutions, veterinary practices, and food safety laboratories across 19+ diagnostic categories worldwide.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industries

Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL), Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH), Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC)

Keywords

• Diagnostic test kits
• Immunoassay products
• ELISA kits
• Veterinary diagnostics
• Clinical laboratory supplies

Headquarters

HQ city

Kiel

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Diagnostic Test Kit Sales: Demeditec generates revenue through the sale of diagnostic test kits including ELISAs, RIAs, IRMAs, and rapid tests. Products are sold directly to clinical laboratories, research institutions, hospitals, universities, and pharmaceutical companies. The company operates on a quote-based pricing model with customized offers.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Demeditec Diagnostics GmbH develops, manufactures, and supplies diagnostic test kits for clinical laboratories and research institutions. Its portfolio covers three technology platforms — ELISA (enzyme-linked immunosorbent assay), RIA (radioimmunoassay), and IRMA (immunoradiometric assay) — plus rapid tests, spanning 19+ categories such as endocrinology, infectious disease, reproductive health, tumor markers, salivary diagnostics, and veterinary diagnostics. The company is ISO 9001 and ISO 13485 certified and distributes products globally through its own website and a strategic partnership with Diagnostics Biochem Canada Inc. (DBC).

Product overview

Demeditec Diagnostics is a supplier of diagnostic test kits for clinical and research laboratories. The product portfolio encompasses three main technology platforms: ELISA (enzyme-linked immunosorbent assay), RIA (radioimmunoassay), and IRMA (immunoradiometric assay). The company serves multiple diagnostic categories including allergy, autoimmunity, biogenic amines, bone metabolism, cardiovascular disease, diabetes, food analytics, infectious disease, reproduction, salivary diagnostics, thyroid function, tumor markers, and veterinary diagnostics. Key products include hormone assays (DHEA ELISA, testosterone/corticosterone/TSH rat/mouse ELISAs), specialty diagnostics (EndomKIT for endometriosis detection), and a comprehensive veterinary diagnostics line covering infectious diseases and species-specific hormone testing. The company also distributes products from Diagnostics Biochem Canada Inc. (DBC), including Total Estrogens ELISA and Glucagon ELISA. Demeditec is certified according to ISO 9001 and ISO 13485.

Differentiator

Problem solved

Functional benefit

Products and services

• DHEA ELISA (DEH3344) Enzyme immunoassay (ELISA, 96 tests, 1 h incubation) for the quantitative determination of Dehydroepiandrosterone (DHEA) in human serum and plasma (EDTA, citrate). CE marked; for clinical laboratories.
• Testosterone rat/mouse ELISA (DEV9911) Enzyme immunoassay for quantitative measurement of testosterone in rat and mouse serum or plasma (standard range 0.1 – 25 ng/ml). Targeted at research laboratories, CROs, and pharmaceutical animal studies.
• Corticosterone rat/mouse ELISA (DEV9922) Enzyme immunoassay for quantitative measurement of corticosterone in rat and mouse serum or plasma (standard range 15 – 2,250 ng/ml). Used in academic and pharmaceutical research.
• TSH rat ELISA (DEV9977) Enzyme immunoassay for quantitative measurement of TSH in rat serum (standard range 2.5 – 80 ng/ml). Marketed as a bestseller.
• EndomKIT ELISA (780001) CE-certified enzyme-immunoassay (ELISA) that combines BDNF and CA125 serum biomarkers with diagnostic medical software for endometriosis detection. Demonstrated 100% specificity in validation studies. Targeted at clinical laboratories and gynecologists.
• Progesterone camel ELISA (DEV8833) Enzyme immunoassay for quantitative measurement of progesterone in serum or plasma of camels, used as a pregnancy test (analytical sensitivity 0.13 ng/ml). Targeted at veterinary practitioners and camel-breeding operations.
• CA125 IRMA (IT2233) Immunoradiometric assay (IRMA, 100 tests, I-125 isotope) for in vitro determination of CA 125 antigen in human serum and plasma. CE marked under EU IVDR. For clinical laboratories performing tumor marker testing.
• Total Estrogens ELISA (CAN-E-630) Competitive ELISA for the quantitative determination of Total Estrogens (estrone, estradiol, estriol) in human serum (standard range 25 – 2,500 pg/ml). Distributed from Diagnostics Biochem Canada Inc. (DBC). CE marking under IVDR planned. For clinical and research laboratories.
• Glucagon ELISA (CAN-GLN-390) Enzyme immunoassay for quantitative measurement of Glucagon in human EDTA plasma. High sensitivity, short incubation, low cross-reactivity, no biotin used. Distributed from Diagnostics Biochem Canada Inc. (DBC). For clinical and research laboratories.
• Veterinary Diagnostics Product Line Comprehensive range of immunoassays for veterinary diagnostics covering infectious diseases (Leishmania, Anaplasma, Babesia, Borrelia, Brucella, Coxiella, Dirofilaria, Echinococcus, Ehrlichia, FeLV, FCoV/FIP, FIV, Giardia, Leptospira, CDV, CPV, Pasteurella, Riemerella, TBE/FSME, Toxocara, Toxoplasma, Trichinella) and species-specific hormone assays. Targeted at veterinary practices, animal researchers, CROs, and pharmaceutical animal studies.
• Soluble alpha-Klotho human ELISA (JP27998) Enzyme immunoassay for quantitative determination of human soluble alpha-Klotho in serum, plasma, urine, and cell culture supernatant (standard range 93.75 – 6,000 pg/ml). Distributed from IBL Japan. For research laboratories.

Quantifiable outcome

• EndomKIT demonstrated 100% specificity in validation studies for endometriosis detection
• +1 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Diagnostics Biochem Canada Inc. (DBC)coreChannel Partner/ Reseller/ Distributor · 23 October 2024DBC and Demeditec established a strategic partnership for the distribution of DBC's ELISA products. The collaboration combines DBC's unique portfolio of endocrinology-based analytes (steroids, hormones, metabolic markers) and specialized niche diagnostic markers with Demeditec's established global distribution network. The partnership strengthens both companies regarding IVDR regulatory compliance.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Emerging players

• MyBioSource: Online-first distributor and manufacturer of ELISA kits and antibodies with a deep catalogue and transparent pricing. Represents the digital-native commercial model Demeditec does not yet operate at scale.
• Elabscience: China-based ELISA kit manufacturer with extensive catalogue at aggressive price points. Increasingly competing in the same research-lab channels as Demeditec, especially for academic and pharma research customers.

Broad incumbents

• DiaSorin: Italian-listed specialty IVD company with a strong immunoassay and CLIA menu. Serves overlapping endocrinology and infectious disease customers but at much greater scale and via automated platforms.
• Tecan (IBL Japan distributor relationship): Switzerland-based life sciences and diagnostics platform with broad immunoassay and reagent offerings. Competes in adjacent specialty assay space and serves similar clinical and research customers.

Direct peers

• Cayman Chemical: US specialty immunoassay and reagent provider with strong assay catalogue in steroids, eicosanoids, and biomarkers. Comparable niche positioning and reliance on research-lab customers.
• Calbiotech: US-based ELISA and CLIA kit manufacturer focused on endocrinology, infectious disease, and autoimmune assays. Comparable as a specialty immunoassay peer without automated-instrument bundling.
• BioVendor Group: Czech-headquartered specialty diagnostics company producing ELISA kits and clinical chemistry assays for research and clinical labs. Similar mid-sized independent profile and immunoassay-led catalogue.
• Eagle Biosciences: US distributor and manufacturer of specialty ELISA/CLIA kits in endocrinology, inflammation, and cancer biomarkers. Overlaps with Demeditec in niche assay distribution to research and clinical labs.
• DRG Instruments: German specialty IVD manufacturer of ELISA and RIA kits for endocrinology, fertility, and infectious disease. Highly comparable product portfolio and customer base to Demeditec, with similar specialty-immunoassay positioning.
• IBL International: Hamburg-based specialty immunoassay manufacturer with strong RIA/ELISA catalogue in endocrinology, neurology, and saliva testing. Closely overlapping with Demeditec's core technologies and customer segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/demeditec

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Demeditec Diagnostics